Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial

about

Clozapine: a review of clinical practice guidelines and prescribing trends Clozapine prescribing in the UK: views and experience of consultant psychiatrists.Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.

P2860

Q21260307-BE0F99C9-AB4B-4B2F-BD8C-C15355E9AABC Q35906545-7B2B4A7F-F486-476C-8D17-CD685B63F227 Q50134375-F4BDB372-6331-46CC-9EDD-688C320B1A0C

P2860

Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial

Item

http://www.wikidata.org/entity/Q37212118

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 April 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Choice of randomization to clo ...... the CATIE schizophrenia trial

@en

Choice of randomization to clo ...... the CATIE schizophrenia trial.

@nl

type

Item

label

Choice of randomization to clo ...... the CATIE schizophrenia trial

@en

Choice of randomization to clo ...... the CATIE schizophrenia trial.

@nl

prefLabel

Choice of randomization to clo ...... the CATIE schizophrenia trial

@en

Choice of randomization to clo ...... the CATIE schizophrenia trial.

@nl

P1476

Choice of randomization to clo ...... the CATIE schizophrenia trial

@en

P2093

Eric Hermes

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for drug-induced akathisia

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

The positive and negative syndrome scale (PANSS) for schizophrenia

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

Results of phase 3 of the CATIE schizophrenia trial.

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

The history of clozapine and its emergence in the US market: a review and analysis.

Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders

P304

1194-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881112443744

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert A. Rosenheck

P577

2012-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22516668

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

3789241

http://www.w3.org/2001/XMLSchema#string

Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial

about

P2860

P2860

Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932